SCHEMBL12366166

SCHEMBL12366166

[C-]#[N+]CC(=O)NCc1ccc(F)c(F)c1F

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 19/20 0.49
CA2 P00918 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366179 0.86 P2RX7 (0.46) P2RX7
SCHEMBL12366170 0.80 CNR1 (0.46) P2RX7
SCHEMBL12366137 0.80 P2RX7 (0.50) P2RX7
SCHEMBL12366133 0.79 HPGD (0.54)
SCHEMBL12261238 0.79 BDKRB1 (0.40) P2RX7
SCHEMBL12366210 0.78 ERCC1 (0.40) P2RX7
SCHEMBL12366161 0.77 RIPK1 (0.38) P2RX7
SCHEMBL28170737 0.76 P2RX7 (0.53) P2RX7CA2
SCHEMBL2263310 0.75 MCL1 (0.51) P2RX7CA2
SCHEMBL12366168 0.75 P2RX7 (0.44) P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed